GlassScriptPhysician profile
Reshma Paresh Maniar
NPI 1366839599
$3,910.42
in general payments reported to CMS, 2019-2025
16 companies · $1,796 in 2025
The $1,796 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $802 · 2022: $719 · 2023: $505 · 2024: $88.49 · 2025: $1,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337 · Travel and Lodging: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.78 |
| Travel and Lodging | $1,052.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,489.71 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Astrazeneca Pharmaceuticals LP | $449.35 | 2021-2023 | Farxiga |
| Impulse Dynamics (USA) INC. | $394.06 | 2022-2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $384.37 | 2021 | |
| Abiomed | $255.28 | 2025 | |
| Janssen Pharmaceuticals, INC | $218.30 | 2021-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.80 | 2021-2024 | Lifevest |
| Novo Nordisk INC | $140.39 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $89.56 | 2023 | |
| Pfizer INC. | $78.92 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $70.49 | 2021-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $48.16 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $36.86 | 2024 | Assure Wcd |
| Amgen INC. | $36.53 | 2023 | Repatha |
| Haemonetics Corporation | $17.14 | 2025 | Teg6s Hemostasis System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reshma Maniar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.